Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127169022 | 12716902 | 2 | F | 20160422 | 20160906 | 20160906 | 20160919 | EXP | FR-PFIZER INC-2016403613 | PFIZER | 17.00 | MON | M | Y | 10.00000 | KG | 20160919 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127169022 | 12716902 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 0.5 MG, 1X/DAY | 1 | MG | U | 71484 | .5 | MG | SOLUTION FOR INJECTION | QD | |||
| 127169022 | 12716902 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | SOLUTION FOR INFUSION | ||||||||
| 127169022 | 12716902 | 3 | SS | DOXORUBICIN-TEVA | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 6.8 MG, 1X/DAY | 14 | MG | U | 0 | 6.8 | MG | QD | ||||
| 127169022 | 12716902 | 4 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 50 MG, 1X/DAY | 100 | MG | D | 0 | 50 | MG | QD | ||||
| 127169022 | 12716902 | 5 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | UNK | 0 | |||||||||||
| 127169022 | 12716902 | 6 | C | MYCOSTATINE | NYSTATIN | 1 | UNK | 0 | |||||||||||
| 127169022 | 12716902 | 7 | C | GRANOCYTE | LENOGRASTIM | 1 | UNK | 0 | |||||||||||
| 127169022 | 12716902 | 8 | C | MESNA EG | MESNA | 1 | UNK | 0 | |||||||||||
| 127169022 | 12716902 | 9 | C | ZOPHREN | ONDANSETRON | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127169022 | 12716902 | 1 | Ewing's sarcoma |
| 127169022 | 12716902 | 2 | Ewing's sarcoma |
| 127169022 | 12716902 | 3 | Ewing's sarcoma |
| 127169022 | 12716902 | 4 | Ewing's sarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127169022 | 12716902 | OT |
| 127169022 | 12716902 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127169022 | 12716902 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127169022 | 12716902 | 1 | 20160420 | 20160421 | 0 | |
| 127169022 | 12716902 | 2 | 20160420 | 20160421 | 0 | |
| 127169022 | 12716902 | 3 | 20160420 | 20160421 | 0 | |
| 127169022 | 12716902 | 4 | 20160420 | 20160421 | 0 |